missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Human Lymphotoxin beta R/TNFRSF3 Antibody, R&D Systems™

Mouse Monoclonal Antibody
Marque: R&D Systems MAB6291-100
Les retours ne sont pas autorisés pour ce produit.
Afficher la politique du retour.
Description
Lymphotoxin beta R/TNFRSF3 Monoclonal specifically detects Lymphotoxin beta R/TNFRSF3 in Human samples. It is validated for Agonist Activity.
Spécification
| Lymphotoxin beta R/TNFRSF3 | |
| 71315 | |
| Agonist Activity 1.5-9 ng/mL | |
| P36941 | |
| Mouse | |
| Protein A or G purified from hybridoma culture supernatant | |
| RUO | |
| Primary | |
| Detects human Lymphotoxin beta R/TNFRSF3 in direct ELISAs. | |
| Human | |
| IgG1 |
| Monoclonal | |
| Unconjugated | |
| Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
| CD18, D12S370, ltbetar, LT-BETA-R, LTBR, lymphotoxin B receptor, lymphotoxin beta receptor (TNFR superfamily, member 3), Lymphotoxin-beta receptor, LymphotoxinbR, TNF RIII, TNF Rrp, TNFCRTNF-RIII, TNFR superfamily, member 3, TNFR2-RP, TNFR3, TNF-R-III, TNFR-RP, TNFRSF3, TNFRSF3TNFR-III, Tumor necrosis factor C receptor, Tumor necrosis factor receptor 2-related protein, tumor necrosis factor receptor superfamily member 3, tumor necrosis factor receptor superfamily, member 3, Tumor necrosis factor receptor type III | |
| Mouse myeloma cell line NS0-derived recombinant human Lymphotoxin beta R/TNFRSF3 Gln31-Met227 Accession # P36941 | |
| 100 μg | |
| Agonist Activity | |
| 4055 | |
| Reconstitute at 0.5 mg/mL in sterile PBS. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu